Analyst Ratings for CG Oncology (CGON )
CGON Rating Summary
CGON Price Target Summary
- Highest: $100.00 (H.C. Wainwright)
- Lowest: $40.00 (Goldman Sachs)
- Average: $81.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$81.67 (+50.1%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
Avg. $ Target:
$81.67 (+50.1%)
* Over Last 12-Mos
Rating Score: 9.4 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/19/2026 | Wolfe Research | Kalpit Patel | New Coverage | Peerperform (N/A) |
N/A (N/A) |
62.93 (54.42) |
-13.52% | Details |
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
85.00 (N/A) |
67.48 (54.42) |
-19.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
